KYMR logo

Kymera Therapeutics, Inc. (KYMR) Return On Equity

Annual ROE:

-36.38%-3.17%(-9.55%)
December 31, 2024

Summary

  • As of today, KYMR annual return on equity is -36.38%, with the most recent change of -3.17% (-9.55%) on December 31, 2024.
  • During the last 3 years, KYMR annual ROE has fallen by -9.42% (-34.94%).
  • KYMR annual ROE is now -34.94% below its all-time high of -26.96%, reached on December 31, 2021.

Performance

KYMR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRprofitability metrics

Quarterly ROE:

-33.29%-0.27%(-0.82%)
September 30, 2025

Summary

  • As of today, KYMR quarterly return on equity is -33.29%, with the most recent change of -0.27% (-0.82%) on September 30, 2025.
  • Over the past year, KYMR quarterly ROE has dropped by -6.10% (-22.43%).
  • KYMR quarterly ROE is now -67.03% below its all-time high of -19.93%, reached on March 31, 2021.

Performance

KYMR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

KYMR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-9.6%-22.4%
3Y3 Years-34.9%+1.2%
5Y5 Years+67.5%-8.3%

KYMR ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-34.9%at low-22.4%+8.7%
5Y5-Year-34.9%+67.5%-67.0%+8.7%
All-TimeAll-Time-34.9%+67.5%-67.0%+65.9%

KYMR ROE History

DateAnnualQuarterly
Sep 2025
-
-33.29%(-0.8%)
Jun 2025
-
-33.02%(-7.2%)
Mar 2025
-
-30.80%(+3.1%)
Dec 2024
-36.38%(-9.5%)
-31.80%(-17.0%)
Sep 2024
-
-27.19%(+9.7%)
Jun 2024
-
-30.10%(+6.6%)
Mar 2024
-
-32.22%(+4.5%)
Dec 2023
-33.21%(-1.9%)
-33.74%(+7.5%)
Sep 2023
-
-36.47%(-6.4%)
Jun 2023
-
-34.28%(+1.2%)
Mar 2023
-
-34.70%(-2.6%)
Dec 2022
-32.60%
-33.81%(-0.3%)
DateAnnualQuarterly
Sep 2022
-
-33.70%(+2.0%)
Jun 2022
-
-34.38%(-5.8%)
Mar 2022
-
-32.50%(-14.2%)
Dec 2021
-26.96%(+5.8%)
-28.47%(-15.0%)
Sep 2021
-
-24.76%(-3.1%)
Jun 2021
-
-24.02%(-20.5%)
Mar 2021
-
-19.93%(+21.6%)
Dec 2020
-28.62%(+74.4%)
-25.42%(+17.3%)
Sep 2020
-
-30.75%(+55.4%)
Jun 2020
-
-69.00%(+29.4%)
Mar 2020
-
-97.67%(-47.7%)
Dec 2019
-111.98%(-103.4%)
-66.14%
Dec 2018
-55.05%
-

FAQ

  • What is Kymera Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual ROE year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly ROE year-on-year change?

What is Kymera Therapeutics, Inc. annual return on equity?

The current annual ROE of KYMR is -36.38%

What is the all-time high annual ROE for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual return on equity is -26.96%

What is Kymera Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, KYMR annual return on equity has changed by -3.17% (-9.55%)

What is Kymera Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of KYMR is -33.29%

What is the all-time high quarterly ROE for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly return on equity is -19.93%

What is Kymera Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, KYMR quarterly return on equity has changed by -6.10% (-22.43%)
On this page